Scalebridge Capital

Scalebridge focuses on seed-stage and early venture rounds, often providing the first institutional capital a startup receives. The firm participates in Series A follow-ons where it holds pro-rata rights. Its model is built around leading initial rounds rather than joining syndicates after terms are set by other investors.

The firm operates as a generalist early-stage investor with concentrated exposure to three verticals: enterprise software, fintech, and digital health. These sectors align with London's strengths in financial services and medical research. Scalebridge does not actively pursue consumer internet, hardware, or deep-tech requiring multi-year R&D timelines.

Origination channels include European accelerator programs, university spinout networks, and angel syndicates active in London and Continental Europe. The firm also receives direct inbound interest from technical founders, particularly those building B2B products who value Scalebridge's willingness to move quickly on term sheets without requiring pre-assembled syndicates.

Scalebridge deploys capital primarily in the United Kingdom and across Continental Europe. The firm has not disclosed investments outside the European region and maintains its sole office in London, which serves as its origination and portfolio management hub.

The firm invests directly into operating companies rather than making fund-of-fund commitments. Scalebridge structures its positions as direct equity investments and maintains capacity for follow-on participation in later rounds where its initial investments warrant continued support.